Abstract
Although most patients with COVID-19 pneumonia have a good prognosis, some patients develop to severe or critical illness, and the mortality of critical cases is up to 61.5%. However, specific molecular information about immune response in critical patients with COVID-19 is poorly understood. A total of 54 patients were enrolled and divided into three groups, among which 34 were common, 14 were severe, and 6 were critical. The constitution of peripheral blood mononuclear cells (PBMC) in patients was analyzed by CyTOF. The profile of cytokines was examined in plasma of patients using luminex. The IL-2 signaling pathway was investigated in the PBMC of patients by qRT-PCR. The count and percentage of lymphocytes were significantly decreased in critical patients compared to common and severe patients with COVID-19 pneumonia. The count of T cells, B cells, and NK cells was remarkably decreased in critical patients compared to normal controls. The percentage of CD8+ T cells was significantly lower in critical patients than that in common and severe patients with COVID-19 pneumonia. The expression of IL-2R, JAK1, and STAT5 decreased in PBMC of common, severe, and critical patients, but IL-2 level was elevated in severe patients and de...Continue Reading
References
Nov 19, 2005·Science·Xinquan WangK Christopher Garcia
Dec 8, 2007·Annual Review of Immunology·Thomas R Malek
Jul 11, 2008·Immunological Reviews·Anne O'GarraCatherine Hawrylowicz
Nov 20, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Elizabeth B Wilson, Alexandra M Livingstone
Oct 4, 2011·Nature Biotechnology·Peng QiuSylvia K Plevritis
May 6, 2014·Journal of Autoimmunity·Yan Bao, Xuetao Cao
Jul 19, 2015·Cancer Letters·Mark H ManninoYujiang Fang
Jul 18, 2016·Experimental Hematology·Kaitlin A ReadKenneth J Oestreich
Aug 6, 2017·Cold Spring Harbor Perspectives in Biology·Toshio TanakaTadamitsu Kishimoto
Nov 25, 2017·Nature Communications·Vincent van UnenBoudewijn P F Lelieveldt
Jun 2, 2018·Biomolecular Concepts·Gunjan KakBrijendra K Tiwari
Jul 8, 2018·Science Immunology·Abul K AbbasJeffrey A Bluestone
Oct 26, 2018·The Journal of Biological Chemistry·Xuanhe FuChenggang Zhang
Nov 6, 2018·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·M Raza Zaidi
Nov 18, 2019·Seminars in Immunology·Tanja BedkeSamuel Huber
Jan 25, 2020·The New England Journal of Medicine·Na ZhuUNKNOWN China Novel Coronavirus Investigating and Research Team
Jan 28, 2020·Lancet·Jasper Fuk-Woo ChanKwok-Yung Yuen
Jan 28, 2020·Lancet·Chaolin HuangBin Cao
Jan 29, 2020·The New England Journal of Medicine·Lan T PhanQuang D Pham
Jan 30, 2020·The New England Journal of Medicine·Qun LiZijian Feng
Feb 3, 2020·Lancet·Nanshan ChenLi Zhang
Feb 8, 2020·JAMA : the Journal of the American Medical Association·Dawei WangZhiyong Peng
Feb 23, 2020·The Lancet. Respiratory Medicine·Zhe XuFu-Sheng Wang
Feb 29, 2020·The New England Journal of Medicine·Wei-Jie GuanUNKNOWN China Medical Treatment Expert Group for Covid-19
Citations
Sep 11, 2020·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Georges Maestroni
Nov 13, 2020·PloS One·Sijiao WangChangzhou Shao
Dec 31, 2020·Scientific Reports·Joonho ParkDohyun Han
Dec 11, 2020·International Immunopharmacology·Ritu Pasrija, Mohammad Naime
Feb 16, 2021·World Journal of Gastroenterology : WJG·Halina Cichoż-Lach, Agata Michalak
Jan 8, 2021·Frontiers in Immunology·Anthony J Leonardi, Rui B Proenca
Nov 4, 2020·Cells·Hibah ShaathNehad M Alajez
Nov 23, 2020·Biochemical and Biophysical Research Communications·Bahire KalfaogluMasahiro Ono
Mar 11, 2021·Heliyon·Sayantan LahaNitai P Bhattacharyya
Mar 13, 2021·Frontiers in Pharmacology·Sajad FakhriJavier Echeverría
Dec 17, 2020·Aging·Jinlian CaiYan Zheng
Apr 1, 2021·European Journal of Immunology·Igor KosMoritz Bewarder
Apr 19, 2021·Life Sciences·Mahnaz GhaebiAbdolreza Esmaeilzadeh
May 10, 2021·The Lancet. Respiratory Medicine·Marcin F OsuchowskiIgnacio Rubio
May 18, 2021·Frontiers in Cellular and Infection Microbiology·Xiaoling QiJialin Liu
Jul 9, 2021·Signal Transduction and Targeted Therapy·Lan YangYufeng Zhou
Aug 7, 2021·Cell Death & Disease·David Della-MorteNicola Di Daniele
Oct 31, 2021·Cell Death & Disease·Andrea SacconiGennaro Ciliberto
Oct 29, 2021·Journal of Medical Virology·Yuji YamamotoAtsushi Kumanogoh